NeLM news service
Bayer Schering Pharma launches moxifloxacin solution for infusion in the UK

Source: Personal Communication from MSD-Plough

Date published: 10/03/2010 16:57

Summary
by: Hina Radia

Bayer Schering Pharma has launched moxifloxacin hydrochloride 400 mg/250 mL solution for infusion (Avelox®) for the treatment of:

 

- Community acquired pneumonia (CAP)
- Complicated skin and skin structure infections (cSSSI)

 

Please see link below for full prescribing information in the SPC.

 

The cost of one pack containing 5 bottles is £199.75

About this library entry
NeLM area:  News

Preview your comment

Add new comment

Comment text:

Comments

There are no comments yet. You could be the first! You must be Logged In to comment.